Human 3d organoids

Human 3D Organoids

Human 3D organoids are in vitro 3D cultures that mimic the structure and function of human organs. They are derived from stem cells, which can self-renew and differentiate into various cell types. Organoids are a powerful in disease modelling, drug development, personalised treatment, and regenerative medicine. 

Human 3D Organoids Read More »

EVs reduce emissions even on Gas electricity

EVs Save Emissions Using Gas

If California’s 340 billion light-duty vehicle miles went electric, consuming 200 watt-hours per mile, it would require an additional 68 TWh/year, 24% of 2023’s 281 TWh generation. There is 4 times unused natural gas capacity, currently not used. Charging during low-use night hours would utilize this excess, reducing pollution and improving efficiency, enhancing air quality and boost ROI on existing infrastructure.

EVs Save Emissions Using Gas Read More »

Tesla Earnings Call Q4 2024

Tesla Earnings Call Q4-2024 Summary

The tone of Tesla’s earnings call for Q4-2024 and full year 2024 today was cautiously optimistic, with Elon Musk emphasizing a significant focus on autonomy and future growth. Despite some disappointing financial results, there was a bullish outlook on AI, FSD, and new vehicle launches, coupled with Musk’s characteristic confidence in Tesla’s future value.

Tesla Earnings Call Q4-2024 Summary Read More »

industrial scale bioplastic production

Industrial-Scale Bioplastic Production

Industrial-scale bioplastic production is being implemented in select regions globally, primarily for applications like packaging, as documented by case studies such as a Malaysian palm biomass biorefinery (20,000 tons/year) and Thailand’s cassava-based PLA and bioplastic bag production demonstrating localized cost and environmental advantages, but broader adoption is limited by high costs, scalability challenges, and performance trade-offs to the 480 million tonne market.

Industrial-Scale Bioplastic Production Read More »

lignin replacing plastic

Lignin Replacing Plastic

Plastic pollution is a growing environmental issue, but innovation in alternative materials offers a solution. Lignin, a natural polymer, can replace many fossil-based plastic products. Other plant-based materials, mycelium, and algae are also being explored as potential plastic alternatives, offering hope for a more sustainable future.

Lignin Replacing Plastic Read More »

Group14 silicon anode batteries

Group14 Silicon Anodes

Nano-silicon anodes are a promising new technology for lithium-ion batteries. They offer 30% superior capacity, faster charging and longer life than traditional graphite anodes. Group 14 is a leading company in this field, and their technology is already being used in smartphones. They are now expanding their production to meet the growing demand for batteries in electric vehicles and other applications.

Group14 Silicon Anodes Read More »

Geologic or Gold hydrogen

Geologic or Gold Hydrogen

Geologic or gold hydrogen has potential to be part of the clean energy transition. Potential LCA and cost is low ($1kg), but there are technological and economic hurdles Co-production of helium with geologic hydrogen could be a key factor in making this technology commercially viable.
Research and development may determine the true potential of geologic hydrogen.

Geologic or Gold Hydrogen Read More »

AI improves clinical trials

AI Improves Clinical Trials

AI is transforming clinical trials by predicting success with 90% accuracy. This could lead to fewer trials, better outcomes, and reduced trial times. Companies like OPYL, OpenAI, and Moderna are at the forefront of this AI-driven healthcare revolution. Using 20 years of past clinical trial data, OPYL can improve trial outcomes by 4 to 5 times, reducing costs and improving success.

AI Improves Clinical Trials Read More »

AI accelerates drug discovery

AI Accelerates Drug Discovery

Within a decade we will cure disease, not just treat it. AI accelerates drug discovery and will reduce cost of new drugs by 4 from $2.4 billion to $600 million, and time from 14 years to 6 years. ROI improves 12 times. AI in medicine will not just improve medicines but will improve diagnosis and treatment.

AI Accelerates Drug Discovery Read More »

Mistrust in Science increasing

Mistrust in Science Increasing

Most research shows Mistrust in science increasing over the past decades and primarily driven by political polarization, amplified by partisan media and social media algorithms that spread misinformation, with variation observed across age, rural vs. urban populations, and political affiliations. Was it the nuclear bomb, or Rachael Carson, but mistrust is increasing rapidly.

Mistrust in Science Increasing Read More »

electrify everthing

Electrify Everything

Electrification promises up to 80% of all global energy requirements and can rapidly stop emissions. In this podcast, Lord Adair Turner points out efficient technologies such as heat pumps, electricity for heating water, air, and materials can rapidly change emissions. The focus shifts from energy consumption to energy services for better human welfare. Solar PV costs at 9 cents/watt and batteries under $100/kWh enable transition.

Electrify Everything Read More »

covid spike protein damages brain

Covid Reduces IQ

New research from Prof Ali Max reveals the COVID-19 spike protein can persist in the body for years, causing brain damage. The protein accumulates in the skull and meninges, leading to inflammation, neuronal damage, and neurodegenerative changes. Long COVID patients exhibit elevated levels of neurodegenerative markers. Vaccination can significantly reduce spike protein accumulation and long-term neurological effects.

Covid Reduces IQ Read More »

Long covid impact

Long Covid Impacts Updated

About one in eight people who get covid-19, also get long covid which is post-infection symptoms persisting for at least a month. Long covid impacts young and is cumulative. Loss of IQ. Loss of fitness, and for some months or years of pain. Long covid is real. Prevention is needed. Masks. Vaccines. Ventilation

Long Covid Impacts Updated Read More »

human cell atlas progress

Human Cell Atlas

The Human Cell Atlas project is revolutionizing our understanding of human biology with its 37 trillion cells and will transform medicine and healthcare. The Atlas provides not only the DNA, but where and how the RNA and control mechanisms operate

It is a testament to the power of collaborative research and the potential of big data to drive scientific discovery.  

Human Cell Atlas Read More »

Stranded gas pipelines in australia

Stranded Gas Assets in Australia

Rapid electrification is forcing gas network companies to seek higher fees by over $200m as they try to protect over $10 billion of stranded assets. As more households switch to electricity, the future of renewable gas remains uncertain. The energy transition challenges policymakers to protect both consumers and gas companies.

Stranded Gas Assets in Australia Read More »

Q&A Renewable Energy

Renewables can supply 100% power, with several countries already achieving high percentages. They are cheaper than fossil fuels, despite rising energy bills due to external factors. While land use is less for renewables, the environmental impact of fossil fuels is significant. Job transitions from fossil fuels to renewables are underway, with potential growth in sectors like battery technology. Renewables offer economic, environmental, and job benefits over fossil fuels.

Q&A Renewable Energy Read More »

Obesity GLP-1 Drugs for winder use

Obesity GLP-1 Drug Use

We have all heard or know of someone who is taking the obesity drug but the exciting news is research going to take the obesity GLP-1 drugs for wider use. A science paper summary of the GLP-1 advances shows how researchers are focusing on other uses.

Obesity GLP-1 Drug Use Read More »

ozempic and GLP-1 drugs other uses

Ozempic and GLP-1 Drugs

Ozempic and other GLP-1 receptor agonists have swept the world for obesity and type 2 diabetes. Their extended value is reducing inflammation and improving clinical outcomes in heart disease by 20% or more. Kidney diseases along with promising but less consistent evidence in liver diseases, while research in autoimmune diseases and dementia remains preliminary.

Ozempic and GLP-1 Drugs Read More »